author-photo

Marscha S. Holleman

Erasmus University Rotterdam

5

Papers

47

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

2019 OncoTargets and Therapy
Show All
- Source
- Cite
- Save
Citations (28)
Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

2019 European Journal of Health Economics
Show All
- Source
- Cite
- Save
Citations (15)
Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data

2019 Value in Health
Show All
- Source
- Cite
- Save
Citations (2)
PRM19 - REPORTING FOLLOW-UP IN SURVIVAL ANALYSES: INFORMATIVE OR NOT?

2018 Value in Health
Show All
- Source
- Cite
- Save
Citations (2)
CE4 - COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE OSIMERTINIB IN PATIENTS WITH EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER

2018 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)